Fundraising Fox
Kupando GmbH
Schönefeld, DE · Founded 2018 · 12 employees on LinkedIn · 4 known investors
Find your way into Kupando GmbH
Sign up to see every warm intro you have to Kupando GmbH
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kupando GmbH team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kupando is a biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases. Its lead candidate KUP101 combines a TLR4 and a TLR7 agonist in a liposomal formulation for treating solid tumors and preventing infectious diseases.
Founders & leadership
Kupando GmbH was founded in 2018 by Johanna Holldack.
Board
PM
Pierre MorgonChairman
WN
Wolfram NothaftDeputy Chairman
Investors · 4
Brandenburg Kapital✓ confirmed by Kupando GmbHPotsdam · $108K – $5.4M
How we know: the company's own site · Not right? Tell us
Remiges Ventures, Inc.✓ confirmed by Kupando GmbHSeattle
How we know: Remiges Ventures, Inc.'s portfolio page · the company's own site · Not right? Tell us
Frequently asked questions
- What does Kupando GmbH do?
- Kupando is a biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases. Its lead candidate KUP101 combines a TLR4 and a TLR7 agonist in a liposomal formulation for treating solid tumors and preventing infectious diseases.
- Who founded Kupando GmbH?
- Kupando GmbH was founded by Johanna Holldack in 2018.
- Who are Kupando GmbH's investors?
- Kupando GmbH's investors include Brandenburg Kapital, Remiges Ventures, Inc., Ventura BioMed Investors, CARMA FUND.
- Where is Kupando GmbH headquartered?
- Kupando GmbH is headquartered in Schönefeld, DE.